Why Cheap Drugs Rarely Get Expensive Cancer Trials
If a drug costs pennies, why hasn't it been proven to work for cancer?
It's a fair question. And the answer is not comfortable.
In modern oncology, proving a drug works is not about theory. It is about evidence. And that evidence comes at a price. A serious Phase III cancer trial can cost $100 million to $500 million.
The System Is Built for Expensive Answers
To change medical practice, a drug must prove it improves survival or quality of life. That requires thousands of patients, years of follow-up, repeated imaging, and strict oversight.
The cost does not care whether the drug is cheap or expensive. The system demands the same level of proof.
The Economic Reality
Now comes the part most people never hear.
If a company spends $200 million proving a drug works, it expects to recover that investment. That is how the system survives.
But with off-patent drugs, anyone can manufacture and sell them. There is no protection. No exclusivity. No way to control pricing.
Even if a cheap generic drug genuinely worked against some cancers, the economic incentive to commercialize it at scale would still be weak because nobody can monopolize the profits.
So even if the trial succeeds, the company that paid for it may never get its money back.
That is not a conspiracy. It is basic economics.
The Gap Between Curiosity and Commitment
Many drugs show interesting effects in the lab. Some affect cancer pathways. Some slow tumor growth in animals.
But before anyone commits hundreds of millions of dollars, one question must be answered:
Does this have a real chance of helping patients in the real world?
If the early signal is weak, inconsistent, or hard to reproduce at safe human doses, the answer is usually no.
And that is where most ideas stop.
Many men reach a point where the information about prostate cancer becomes seriously overwhelming. Different opinions. Different options. No clear path forward.
If you would like to step back and think clearly before making any decisions, you are welcome to contact me. I will read your situation personally and respond thoughtfully.
No pressure. No sales pitch. Just a calm, focused exchange to help you see things clearly.
Where the Warrior Mindset Matters
This is where emotion and reality must separate.
It is easy to believe that powerful forces are holding back simple solutions. It is harder to accept that biology is complex, and most ideas fail when tested properly.
But ignoring the system does not change it.
Understanding it does.
The Truth That Gives You Power
Cheap drugs face a funding gap. That is real.
But they also face the same test as every cancer treatment: they must prove they work in humans, not just in theory.
Until the evidence is strong enough to justify a $200 million decision, progress will remain slow.
Bottom Line
This is not about belief. It is about proof.
The system rewards what can be proven, not what sounds promising.
Proving a cheap drug works in cancer isn't a $20M decision, it's often a $200M–$500M decision.
And when no one can own the result, funding becomes extremely difficult, unless the early signal is so strong it forces action.
Until then, the battlefield is not opinion. It is evidence.
About the Author
Scott Oliver, 66, is living well with prostate cancer after dedicating more than 4,000 hours to researching the condition. His first goal is to help men reduce their risk of developing prostate cancer through proven lifestyle strategies.
When diagnosed, his mission is to help men avoid unnecessary prostate surgeries that can lead to devastating complications such as incontinence, bleeding, permanent impotence, and a loss of length.
Scott Oliver is not a doctor and does not offer medical advice; however, he is healthier and fitter than he has been in decades. Through his articles and videos, he shares hard-to-find, uncensored information on proven alternative therapies, effective fitness methods, and repurposed drugs, content that most doctors won’t mention and search engines suppress.
He is an accredited member of the National Writers Union (NWU) and the International Federation of Journalists (IFJ), the world’s largest organization of professional journalists. Scott is also the author of What If Cancer’s Best Defense Is Free? Sleep as a Defense Against Cancer: A Former Royal Marines Commando’s 4,000-Hour Research Roadmap, where he reveals how sleep repairs DNA, restores immunity, and strengthens the body’s natural defenses against cancer.
You can always contact Scott Oliver here with your questions and suggestions.